Capital Fund Management S.A. Invests $43.29 Million in HCA Healthcare, Inc. (NYSE:HCA)

Capital Fund Management S.A. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 144,236 shares of the company's stock, valued at approximately $43,292,000. Capital Fund Management S.A. owned 0.06% of HCA Healthcare as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Evexia Wealth LLC lifted its holdings in shares of HCA Healthcare by 6.6% during the fourth quarter. Evexia Wealth LLC now owns 9,748 shares of the company's stock worth $3,139,000 after purchasing an additional 601 shares during the period. CenterBook Partners LP acquired a new stake in HCA Healthcare in the fourth quarter valued at about $1,962,000. APG Asset Management N.V. increased its holdings in shares of HCA Healthcare by 125.2% in the 4th quarter. APG Asset Management N.V. now owns 178,206 shares of the company's stock valued at $51,655,000 after purchasing an additional 99,083 shares in the last quarter. Renaissance Group LLC raised its position in HCA Healthcare by 4.1% during the fourth quarter. Renaissance Group LLC now owns 92,645 shares of the company's stock worth $27,807,000 after acquiring an additional 3,607 shares during the last quarter. Finally, Rathbones Group PLC lifted its position in shares of HCA Healthcare by 1.7% in the fourth quarter. Rathbones Group PLC now owns 48,317 shares of the company's stock valued at $14,502,000 after acquiring an additional 787 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.3 %

HCA traded down $4.38 during midday trading on Tuesday, hitting $336.24. 445,916 shares of the company were exchanged, compared to its average volume of 1,386,544. The firm has a market capitalization of $82.78 billion, a P/E ratio of 15.30, a P/E/G ratio of 1.10 and a beta of 1.48. The firm's 50 day moving average price is $327.61 and its 200-day moving average price is $335.63. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the company posted $5.90 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's payout ratio is presently 13.11%.

Analysts Set New Price Targets

HCA has been the topic of several research reports. Robert W. Baird restated a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday. KeyCorp lowered their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Barclays decreased their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. StockNews.com lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Wednesday, April 9th. Finally, Royal Bank of Canada decreased their price objective on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $381.67.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.